Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | OPRD1 | P41143 | 6/20 | 0.55 |
| ▸ | KEAP1 | Q14145 | 1/20 | 0.54 |
| ▸ | HCRTR1 | O43613 | 1/20 | 0.53 |
| ▸ | HCRTR2 | O43614 | 1/20 | 0.53 |
| ▸ | NTSR1 | P30989 | 4/20 | 0.53 |
| ▸ | NTSR2 | O95665 | 2/20 | 0.52 |
| ▸ | SORT1 | Q99523 | 2/20 | 0.52 |
| ▸ | CALCR | P30988 | 4/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29845666 | 0.92 | OPRD1 (0.56) | OPRD1HCRTR1HCRTR2NTSR1NTSR2 | |
| SCHEMBL29352283 | 0.88 | MAPK8 (0.49) | HCRTR1HCRTR2NTSR1NTSR2SORT1 | |
| SCHEMBL30607304 | 0.87 | CALCR (0.57) | OPRD1HCRTR1HCRTR2CALCR | |
| SCHEMBL30712934 | 0.85 | CALCR (0.62) | HCRTR1HCRTR2CALCR | |
| SCHEMBL30431868 | 0.85 | NPY2R (0.57) | OPRD1HCRTR1HCRTR2CALCR | |
| SCHEMBL30567787 | 0.84 | CALCR (0.61) | HCRTR1HCRTR2CALCR | |
| SCHEMBL30432870 | 0.83 | NPY2R (0.59) | CALCR | |
| SCHEMBL29500553 | 0.83 | APLNR (0.62) | OPRD1KEAP1HCRTR1HCRTR2CALCR | |
| SCHEMBL30401788 | 0.81 | NPY2R (0.52) | CALCR | |
| SCHEMBL31182773 | 0.81 | CALCR (0.66) | OPRD1KEAP1HCRTR1HCRTR2CALCR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4299761-B1 | SURFACE-FUNCTIONALIZED OPTICAL ELEMENT | BETASENSE GMBH (DE) | 2026-05-27 | — | — | EP | disclosed |
| US-20260002946-A1 | SURFACE-FUNCTIONALIZED OPTICAL ELEMENT | BETASENSE GMBH (DE) | 2026-01-01 | — | — | US | disclosed |
| CN-119236095-A | Inflammatory microenvironment responsive cross-linked polypeptide modified liposome | 大理大学 | 2025-01-03 | — | — | CN | disclosed |
| US-20240190937-A1 | HUMAN INSULIN C-ALPHA-PEPTIDES AND METHODS OF USE | THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPT. OF HEALTH AND HUMAN SERVICES (US) | 2024-06-13 | — | — | US | disclosed |
| WO-2024101935-A1 | AMPHIPHILIC CONJUGATE COMPRISING SELF-ASSEMBLIYABLE PEPTIDE MOLECULE AND USE THEREOF | 울산과학기술원 | 2024-05-16 | — | — | WO | disclosed |
| EP-4326311-A1 | HUMAN INSULIN C-ALPHA-PEPTIDES AND METHODS OF USE | The United States of America, as represented by the Secretary, Department of Health and Human Services (US) | 2024-02-28 | — | — | EP | disclosed |
| WO-2024003214-A2 | SURFACE-FUNCTIONALIZED OPTICAL ELEMENT | BETASENSE GMBH (DE) | 2024-01-04 | — | — | WO | disclosed |
| EP-4299761-A1 | SURFACE-FUNCTIONALIZED OPTICAL ELEMENT | betaSENSE GmbH (DE) | 2024-01-03 | — | — | EP | disclosed |
| WO-2022226197-A1 | HUMAN INSULIN C-ALPHA-PEPTIDES AND METHODS OF USE | THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) | 2022-10-27 | — | — | WO | disclosed |
| CN-113304267-B | Therapeutic target of lung cancer and application thereof | 河南大学 | 2022-03-15 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260002946-A1 | SURFACE-FUNCTIONALIZED OPTICAL ELEMENT | ATR, ATRIP, IGF1R | OPRD1 1203/4885KEAP1 1158/4885HCRTR1 2209/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.